NCT05122962View on ClinicalTrials.gov

Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases

RecruitingOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Tetralogy of FallotCongenital Heart Disease
Interventions
DIAGNOSTIC_TEST

Remote Heart Rhythm Monitoring

We will be looking to see if remote heart rhythm monitoring for 30 days at baseline, 12, and 24 months, helps for early identification of adverse cardiac events.

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Mayo Clinic

OTHER

NCT05122962 - Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases | Biotech Hunter | Biotech Hunter